Ryman rights trading ends on a sour note

Ryman rights trading ends on a sour note
Salt Funds' Matt Goodson said time will tell whether Ryman shares are cheap. (Image: Salt Funds)
Jenny Ruth
Ryman Healthcare’s $902 million rights issue is drawing to a dismal close, with the price of the rights falling as low as 7.5 cents on Tuesday, the last day of trading.Two weeks ago, in the institutional book-build auction process, institutional investors were prepared to pay an effective $1 for the rights.You could say that was a little disappointing because the theoretical value of the rights price was $1.03 – institutions paid $6 for the shares issued at $5, so the additional price paid reflected the value they put on the rights....

More Finance

RBNZ reopens Wellington office after asbestos mayhem
Finance

RBNZ reopens Wellington office after asbestos mayhem

Bank tight-lipped on how many staff are home-working as asbestos-hit office reopens. 

Andy Macdonald 21 Nov 2025
Big banks eye warnings on legacy Open Banking technology
Finance

Big banks eye warnings on legacy Open Banking technology

Their interest comes with dawn of API-led Open Banking just weeks away. 

Andy Macdonald 19 Nov 2025
Banks accelerate crackdown on ‘mule’ scammers
Finance

Banks accelerate crackdown on ‘mule’ scammers

New technology picks up crooked “muleteers” more quickly.

Andy Macdonald 17 Nov 2025
NZX edges lower as Infratil, profit-taking weigh
Finance Market close

NZX edges lower as Infratil, profit-taking weigh

S&P/NZX 50 Index slips with Infratil, Blackpearl and Heartland in focus.

Andy Macdonald 13 Nov 2025